Udg Healthcare (UDHCF) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Udg Healthcare (OTCMKTS:UDHCF) from a hold rating to a buy rating in a research note released on Friday. Zacks Investment Research currently has $8.75 price objective on the stock.

According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “

Shares of UDHCF opened at $7.71 on Friday. Udg Healthcare has a one year low of $7.71 and a one year high of $12.95.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.

Featured Story: What is a conference call?

Get a free copy of the Zacks research report on Udg Healthcare (UDHCF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply